Rottlerin
January 15, 2020
Silybin (Milk Thistle)
January 15, 2020
Sansalvamide A (MArine Fungi Fusarium)
- A comprehensive study of Sansalvamide A derivatives: The structure–activity relationships of 78 derivatives in two pancreatic cancer cell lines
- A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest
- A novel sansalvamide analogue inhibits pancreatic cancer cell proliferation via induction of macrophage inhibitory cytokine (MIC-1)
- Comprehensive study of Sansalvamide A derivatives and their structure–activity relationships against drug-resistant colon cancer cell lines
- Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives
- Design, synthesis, and biological activity of Sansalvamide A derivatives
- Design, synthesis, and mechanistic studies of Sansalvamide A derivatives as anti-cancer agents
- Effect of the 4′-substituted phenylalanine moiety of Sansalvamide A peptide on antitumor activity
- Evaluation of di-Sansalvamide A derivatives: synthesis, structure− activity relationship, and mechanism of action
- Highly efficient macrolactonization of ω-hydroxy acids using benzotriazole esters: synthesis of Sansalvamide A
- High-yielding macrocyclization conditions used in the synthesis of novel Sansalvamide A derivatives
- Identification of Sansalvamide A analog potent against pancreatic cancer cell lines
- Ionic‐Liquid‐Supported Total Synthesis of Sansalvamide A Peptide
- Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A
- Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90
- N-Triethylene glycol (N-TEG) as a surrogate for the N-methyl group: application to Sansalvamide A peptide analogs
- PANCREATIC CANCER CELL CYCLE ARREST AND APOPTOSIS ARE INDUCED BY A NOVEL DEPSIPEPTIDE SANSALVAMIDE ANALOGUE
- PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide
- PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A derivative
- Photo-induced synthesis and in vitro biological activity of a Sansalvamide A analog
- Rapid, high-yield, solid-phase synthesis of the antitumor antibiotic Sansalvamide A using a side-chain-tethered phenylalanine building block
- Sansalvamide A and heat shock protein 90 biochemical and binding studies
- Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium
- Solid-phase, Pd-catalyzed silicon-aryl carbon bond formation. Synthesis of Sansalvamide A peptide
- Structure-activity of Sansalvamide A derivatives and their apoptotic activity in the pancreatic cancer cell line PL-45
- Synthesis and cytotoxicity of novel Sansalvamide A derivatives
- Synthesis and evaluation of biotinylated Sansalvamide A analogs and their modulation of Hsp90
- Synthesis and novel structure–activity relationships of potent Sansalvamide A derivatives
- Synthesis of Cyclic Pentadepsipeptoids Analogues of Sansalvamide A by Combination of Ugi and Passerini Reactions
- Synthesis of macrocyclic anticancer agents: Sansalvamide A derivatives and Urukthapelstatin A
- Synthesis of N-OEG analogs of the Sansalvamide A peptide and evaluation of their biological activity
- Synthesis of Radioiodinated Antitumor Cyclic Peptide,[125I]-Sansalvamide A Derivative
- Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29
- Synthesis of Sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds
- Synthesis of second-generation Sansalvamide A derivatives: Novel templates as potential antitumor agents
